Renol Polychem IPO Details
SME
Renol Polychem IPO opens for subscription on 31 Jul 2025 and closes on 04 Aug 2025. The IPO will be listed on NSE with the tentative listing date set for 07 Aug 2025.
Renol Polychem IPO price band has been fixed at ₹100 – ₹105 per share.The face value is ₹10 per share with a lot size of 1200.
Renol Polychem IPO total issue size comprises 24,54,000 shares (aggregating up to ₹25.77 Cr). This includes a fresh issue of 24,54,000 shares (aggregating up to ₹25.77 Cr). Pre-issue shareholding stands at 54,90,000, which will increase to 79,44,000 post-issue.
Renol Polychem IPO carries a ₹3 (2.86%) GMP, reflecting investor sentiment.
Renol Polychem IPO Lot Size : Individual Minimum is 2 lots (2,400 shares) amounting to ₹252,000. Individual Maximum is 2 lots (2,400 shares) amounting to ₹252,000. SHNI Minimum is 3 lots (3,600 shares) amounting to ₹378,000. SHNI Maximum is 7 lots (8,400 shares) amounting to ₹882,000. BHNI Minimum is 8 lots (9,600 shares) amounting to ₹1,008,000.
The Lead Managers for Renol Polychem IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Corporate Makers Capital Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For detailed information, Refer to the Renol Polychem Limited RHP.
Renol Polychem IPO Details
Renol Polychem IPO Subscription
Renol Polychem IPO Application Wise Breakup
Renol Polychem IPO Dates
- 31 Jul 2025Opening dateOpen
- 04 Aug 2025Closing dateClose
- 05 Aug 2025Allotment Date Allotment
- 06 Aug 2025Initiation of RefundsRefund
- 06 Aug 2025Credit of SharesCredit
- 07 Aug 2025Listing dateListing
Renol Polychem IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual Minimum | 2 | 2400 | ₹252,000 |
| Individual Maximum | 2 | 2400 | ₹252,000 |
| SHNI Minimum | 3 | 3600 | ₹378,000 |
| SHNI Maximum | 7 | 8400 | ₹882,000 |
| BHNI Minimum | 8 | 9600 | ₹1,008,000 |
Renol Polychem IPO Reservation
Promoter Holding
Renol Polychem IPO Valuations
Renol Polychem Financial Information
| Period Ended | 31 May 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 25.86 | 23.41 | 15.49 | 10.28 |
| Revenue | 12.02 | 62.56 | 6.52 | 41.86 |
| Profit After Tax | 1.14 | 5.00 | 1.53 | 0.73 |
| EBITDA | 1.60 | 7.07 | 2.18 | 1.14 |
| Net Worth | 14.47 | 13.33 | 8.69 | 2.71 |
| Reserves and Surplus | 8.98 | 7.84 | 3.20 | |
| Total Borrowing | 5.28 | 6.95 | 2.58 | 5.36 |
| Amount in ₹ Crore | ||||
About Renol Polychem IPO
Incorporated in 2008, Renol Polychem Limited is a manufacturer and supplier specializing in colour masterbatches, plastic masterbatches, industrial chemicals, impact modifiers, plastic pigments, and more.
Their product range includes various color masterbatches such as green, red, yellow, orange, pink, blue, brown, violet, ivory, white, maroon, silver, multicolor, and black, as well as transparent plastic filler masterbatches.
The company offers all-in-one additives, including stabilisers, impact modifiers, and colour pigments, to assist manufacturers of UPVC, CPVC pipes, pipe fittings, and other plastic products.
Renol Polychem Limited offers a wide variety of masterbatches and polymer solutions, including:
- Colour Masterbatches Green, Red, Yellow, Orange, Pink, Blue, Brown, Violet, Ivory, White, Maroon, Silver, Multicolor, and Black Masterbatches. Specially formulated masterbatches for plastic moulding, extrusion, and film applications.
- Filler Masterbatches Transparent Plastic Filler Masterbatches Talc and Calcium Carbonate-based filler masterbatches for improving cost efficiency and mechanical properties in plastic production.
- Additive Masterbatches UV Stabilizers Antioxidants Slip & Anti-block Agents Processing Aids Flame Retardants.
- Polymer Compounds & Pigments High-performance plastic pigments Polymer modifiers to enhance strength, flexibility, and durability.
The company's products find application in industries such as plastic packaging (flexible and rigid), Automotive Components, Household & Consumer Goods, Electrical & Electronics, Textiles & Fibers and Agricultural Films & Pipes.
As of September 30, 2024, the company had 15 employees in various departments.
Strength Of Renol Polychem IPO
1. Diversified Product Portfolio Offering offered.
2. Strong Client base.
3. Experience of our Promoter and core management team.
4. Quality Assurance.
5. Cost competitiveness and time bound delivery.
Risk Of Renol Polychem IPO
1. Extensive government regulation and the impact of plastics and related on the environment could have a severe impact on our ability to continue our business operations, which could adversely affect our business, results of operations and financial condition.
2. Our continued operations are critical to our business and any shutdown of our manufacturing unit may adversely affect our business, results of operations and financial condition.
3. In addition to our existing indebtedness for our existing operations, we may incur further indebtedness during the course of business. We cannot assure that we would be able to service our existing and/ or additional indebtedness.
4. Substantial portion of our revenues has been dependent upon few clients. The loss of any one or more of our major clients would have a material effect on our business operations and profitability.
5. Our Company has experienced negative cash flow in the past and may continue to do so in the future, which could have a material adverse effect on our business, prospects, financial condition, cash flows and results of operations.
6. Our Registered Office, manufacturing unit and warehouse(s) are located on rental premises. If we are unable to renew such rent agreements or relocate on commercially suitable terms, it may have a material adverse effect on our business, results of operation and financial condition.
7. Our business is operating under various laws which require us to obtain approvals from the concerned statutory/regulatory authorities in the ordinary course of business and our inability to obtain, maintain or renew requisite statutory and regulatory permits and approvals for our business operations could materially and adversely affect our business, prospects, results of operations and financial condition.
8. There have been certain instances of non-compliances in respect of ROC filing or payments. Any penalty or action taken by any regulatory authorities in future for non-compliance with provisions of all applicable law and other law could impact on the financial position of the Company to that extent.
9. We derive significant portion of our revenue from sale of limited variety of our products. An inability to adapt to evolving consumer preferences and demand for particular products, or ensure product quality may adversely impact demand for our products and consequently our business, results of operations, financial condition and cash flows.
10. Our Company does not have long term agreements with suppliers for supply of raw material. Our inability to obtain raw material in a timely manner, in sufficient quantities could adversely affect our operations, financial condition and/or profitability.
Objectives Renol Polychem IPO
1. Capital Expenditure in requirements for the purchase of Machinery
2. Repayment of certain borrowings
3. To meet out the Working Capital Requirements
4. General Corporate Purposes
Company Contact Details
Renol Polychem Ltd.
307, Sanskar Heights NR RA
Circle 150 FT Ring RD,
Mavdi,
Rajkot, Gujarat, 360004
Phone: +91- 9723780726
Email: compliance@renolpolychem.com
Website: https://www.renolpolychem.com/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Market Maker
To be announced
Renol Polychem IPO - FAQs
The Renol Polychem IPO is a SME public issue comprising 2454000 equity shares with a face value of ₹10 each, aggregating to a total issue size of ₹25.77 Cr. The issue price has been fixed at ₹105 per equity share, and the minimum application size is 1200 shares.
The IPO opens for subscription on 31 Jul 2025, and closes on 04 Aug 2025.
Skyline Financial Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE
As of now, the current GMP stands at ₹3 (2.86%).